fda bpc-157 warning unapproved drug panel narrowly backs peptide drugs – NBC4 Washington F.D.A. Panel's Vote on Peptides

The lack of B12 is the limiting factor for creating new blood cells

Diagnostic pathway inefficiencies create additional delays

In Drosophila , our recent data reveal that uqcr-c1 associates with cyt c in mitochondria to gate its release (Hung et al., 2021)

PNPLA1 defects in patients with autosomal recessive congenital ichthyosis and KO mice sustain PNPLA1 irreplaceable function in epidermal omega- O -acylceramide synthesis and skin permeability barrier

It is widely used in regenerative settings because it supports tissue repair across multiple systems, particularly connective tissue

Sheep and cattle with low levels of selenium or at risk of clinical deficiency should be treated with a suitable long-acting therapy, such as Selovin LA from Elanco